#1292ef

Tiefenbacher Group

#f9f9f9

Stefanie Abt

Dieter Schoenfeld

Sayan Sarkar

Dennis Kuck

Kristian Ruepp

Petra Beckers

Sandra Thiel

Susanne Boberg

Ekaterina Lebedeva

TIEFENBACHER GROUP
Pioneering
Healthcare
Contact
Advanced Pharmaceuticals
MAKING A DIFFERENCE
IN PEOPLE`S HEALTH
More
Raw Material
YOUR EXPERT IN SOURCING
AND SUPPLYING APIS
More
RESEARCH AND DEVELOPMENT
HIGHEST DEMANDS ON
FORMULATIONS
AND INNOVATION
More
MANUFACTURING
DRIVING EFFICIENCY
DURING THE WHOLE
PRODUCTION PROCESS
More
MEDICAL DEVICES
COMBINING
MEDICINES WITH
eHEALTH SOLUTIONS
More
Market Access
BREATHING LIFE
INTO MARKETS
More
Raw Material
R&D
Manufacturing
Medical Device
Market Entry
ISO 13485 compliant
Highest quality standards
We ensure a high level of quality, safety, and reliability by our highly effective quality management system for the design, development, and manufacturing of our innovative medical device solutions. We establish our processes in compliance with the current international regulations such as ISO 13485:2016 and MDR 2017/74.
X
Combining medical
devices and e-health
Best-in-class solution
We offer better therapies for patients by combining medicines, medical devices, and e-health technology. Our innovative solutions enable individual treatments and create added value for the entire healthcare system by digitally connecting patients, doctors, and payers.
X
100% Patient-centric
closer to the patient than ever before
Every year we serve over 500 million patients with our generic, value added and innovative products. All our activities are focused on creating pharmaceuticals ? in a patient-centric approach ? more available, more affordable, and better than before. To better understand patients? needs we are in close and regular collaboration with universities and key opinion leaders of all relevant disciplines ?getting closer to the patient than ever. Patient insights drive our portfolio strategy of creating a new generation of pharmaceuticals for better healthcare.
X
First NCE approved
Always striving for better therapies
Ever since the company was established by Alfred E. Tiefenbacher in 1963, TIEFENBACHER GROUP has been pioneering healthcare to improve patients? lives around the world. We always challenge the status quo by being one step ahead. We don?t only aim to make high-quality pharmaceuticals better affordable and better available than before; we also strive for better therapies for the benefit of patients. In 2019, TIEFENBACHER PHARMACEUTICALS successfully gained the first European NCE approval for an advanced drug being used to treat the symptoms of insomnia in a better and safer way.
X
Frequent day-one launches
market entry at the earliest possible time
Especially in the generic drug industry, the timing of the market entry is crucial for market success. We at TIEFENBACHER PHARMACEUTICALS always aim to be the first on the market after patent expiry. Thanks to our exceptional experience and expertise in research and development, regulatory affairs, and patent management, we deliver constantly day one-launches. This makes our high-quality pharmaceuticals better available and better affordable for patients around the world at the earliest possible time.
X
Regulatory Affairs (RA)
abundant practical experience: from development to maintenance
Regulatory Affairs plays a crucial role throughout the lifecycle of pharmaceuticals: from drug development, through the submission of a marketing authorization, to commercialization. We ensure that products are developed, manufactured, and controlled at all levels of expected quality, safety, and efficacy. Our Regulatory Affairs experts provides strategic and technical expertise at the highest level to maintain the goal of timely commercialization of our generic, value added, and innovative drugs. Even after drug approval and commercialization, we ensure that approval is maintained during the product?s life cycle.
X
350+ tender awards in 12 month
Strong track record of successful tender proposals
Tendering is a common practice for multisource pharmaceuticals in most countries worldwide. TIEFENBACHER PHARMACEUTICALS has a strong track record in winning tenders for its customers.
Through efficient supply chain management and in-house manufacturing capabilities we offer the best prices and a stable and secure supply ? being important requirements for a successful bidding process. By ensuring good tender practices, we can make an important contribution to the stability and accessibility of health services, in addition to the efficient use of financial resources.
X
150+ marketing

The powerhouse for next generation pharmaceuticals: high-quality FDF + highly potent drugs for better healthcare worldwide I in-house R&D